质量(理念)
设计质量
过程(计算)
风险分析(工程)
过程管理
控制(管理)
计算机科学
药品
订单(交换)
上游(联网)
下游(制造业)
医学
药理学
工程类
运营管理
业务
人工智能
计算机网络
哲学
认识论
财务
操作系统
作者
Nicholas M. Thomson,Robert A. Singer,Kevin D. Seibert,Carla V. Luciani,Sushil Srivastava,William F. Kiesman,Erwin Irdam,John Lepore,Luke Schenck
标识
DOI:10.1021/acs.oprd.5b00146
摘要
A series of case histories from IQ consortium member companies are presented in order to exemplify many of the different elements of drug substance control strategies that are required in order to ensure process performance and product quality. Control through process, method, and/or model design can combine to form a holistic control strategy that effectively manages risk and assures quality for the patient. A typical drug substance control strategy overview is presented, along with a number of detailed case histories that aim to demonstrate the use of process design and the development of methods and modeling to ensure control of critical quality attributes where appropriate, whether in the final drug substance or through upstream controls.
科研通智能强力驱动
Strongly Powered by AbleSci AI